High Tower Advisors, LLC Bridge Bio Pharma, Inc. Transaction History

High Tower Advisors, LLC

$84.5 Billion
Q3 2025

A detailed history of High Tower Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 230,393 shares of BBIO stock, worth $15.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

230,393

Previous 228,386 0.88%

Holding current value

$15.3 Million

Previous $9.86 Million 21.35%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$42.78 - $54.29 $85,859 - $108,960	2,007 Added 0.88%	230,393 $12 Million
Q2 2025 Aug 11, 2025	BUY	$30.14 - $45.12 $7,565 - $11,325	251 Added 0.11%	228,386 $9.86 Million
Q1 2025 May 12, 2025	SELL	$28.12 - $37.59 $5,539 - $7,405	-197 Reduced 0.09%	228,135 $7.89 Million
Q4 2024 Feb 07, 2025	BUY	$22.35 - $29.5 $111,772 - $147,529	5,001 Added 2.24%	228,332 $6.27 Million
Q3 2024 Nov 14, 2024	BUY	$23.91 - $31.3 $527,861 - $691,010	22,077 Added 10.97%	223,331 $5.69 Million

Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $45,816 - $61,831	1,992 Added 1.0%	201,254 $5.1 Million
Q1 2024 May 06, 2024	SELL	$27.35 - $40.45 $27,869 - $41,218	-1,019 Reduced 0.51%	199,262 $6.16 Million
Q4 2023 Feb 12, 2024	BUY	$24.02 - $43.89 $25,100 - $45,865	1,045 Added 0.52%	200,281 $8.09 Million
Q3 2023 Nov 08, 2023	SELL	$16.89 - $35.01 $411,727 - $853,438	-24,377 Reduced 10.9%	199,236 $5.25 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $199,350 - $270,150	15,000 Added 7.19%	223,613 $3.85 Million
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $1,634 - $4,229	228 Added 0.11%	208,613 $3.46 Million
Q2 2022 Aug 10, 2022	BUY	$5.21 - $12.14 $599 - $1,396	115 Added 0.06%	208,385 $1.89 Million
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $78,185 - $182,788	-10,652 Reduced 4.87%	208,270 $2.12 Million
Q4 2021 Feb 10, 2022	BUY	$11.38 - $53.41 $82,891 - $389,038	7,284 Added 3.44%	218,922 $3.65 Million
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $474,793 - $650,751	-10,130 Reduced 4.57%	211,638 $9.92 Million
Q2 2021 Aug 06, 2021	BUY	$46.47 - $63.93 $139 - $191	3 Added 0.0%	221,768 $13.5 Million
Q1 2021 May 10, 2021	BUY	$55.47 - $72.35 $75,272 - $98,178	1,357 Added 0.62%	221,765 $13.7 Million
Q4 2020 Feb 10, 2021	BUY	$38.38 - $71.11 $3,838 - $7,111	100 Added 0.05%	220,408 $15.7 Million
Q1 2020 May 21, 2020	BUY	$16.11 - $36.23 $3.55 Million - $7.98 Million	220,308 New	220,308 $6.39 Million

Others Institutions Holding BBIO

# of Institutions

446

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Bridge Bio Pharma, Inc. Transaction History